Flo Health reaches Unicorn status, secures more than $200M in new funding

Flo Health, one of the most downloaded women's health apps globally, has secured over $200M in a Series C funding round from General Atlantic. This investment boosts Flo's valuation beyond $1 billion, making it the first digital women's health app to achieve unicorn status.

Flo is dedicated to supporting women throughout their health journeys, from menstruation to conception, pregnancy, and menopause. With the expertise of over 120 doctors and health professionals, Flo’s comprehensive platform provides curated cycle and ovulation tracking. Users can monitor more than 70 symptoms and utilise features that enhance their understanding and management of their health. Flo offers tailored health insights, expert advice, daily visual content, and access to a private digital discussion community on health and wellness. In 2023, Flo introduced ‘Flo for Partners’, empowering users to educate their partners with scientific insights into menstrual and reproductive health. Flo’s 'Anonymous Mode' feature, honoured as one of Time’s Best Inventions 2023, was developed to protect sensitive reproductive health information.

The partnership with General Atlantic aims to drive Flo's next growth phase, focusing on new user segments like perimenopause and menopause, improving tech-driven health insights, and exploring strategic expansion opportunities. Flo plans to increase its R&D team by investing in top talent across its European and North American offices. The company also intends to leverage General Atlantic’s expertise in scaling companies at the intersection of consumer technology, healthcare, and subscription business models.

This milestone cements Flo's position as a leader in the burgeoning femtech market, which has grown from a niche sector with minimal venture capital investment a decade ago to a projected $60 billion industry by 2027. Flo has experienced significant growth over its eight years of continuous expansion. As of June 2024, the app supports nearly 70 million monthly active users (MAUs) and close to 5 million paid subscribers. Flo's gross bookings for 2024 are expected to surpass $200 million, marking an approximately 50% year-over-year increase.

"Reaching unicorn status is a significant milestone for Flo and the entire femtech industry," said Dmitry Gurski, co-founder and CEO of Flo Health. "When we started Flo, we identified a huge gap in women's health services. Now, we're a leader in a global movement to make women's health a priority everywhere. We're already helping hundreds of millions of women, and our goal is to reach 1 billion women through our global pro-social program. This initiative provides free access to Flo Premium across 66 countries, including India, Indonesia, and Nigeria, with nearly 12 million women already benefiting. We're committed to building a better future for female health, where every woman feels understood and supported, regardless of her location or economic status. This investment from General Atlantic will help propel Flo Health’s growth as we continue normalising conversations about women's health, improving health literacy, and raising awareness of women's health issues worldwide, especially in underserved regions.”

Jessie Cai, Principal at General Atlantic, commented, “We have been lucky enough to watch the Flo team over the past five years build a beloved, mission-critical app for women globally, and now we have the fortunate opportunity to partner with Dmitry and his team. We are excited about their big vision and the innovation ahead for the broader women’s health and wellness ecosystem. We believe Flo is a category leader and look forward to leveraging our deep expertise across disruptive consumer technology and subscription platforms to support the company’s continued growth.”

"This investment accelerates Flo's mission to revolutionise women's health," said Anna Klepchukova, Chief Medical Officer of Flo Health. "With women spending 25% more of their lives in poor health compared to men, we're committed to changing this unacceptable status quo. As the #1 OB-GYN-recommended cycle tracking app, Flo empowers users with tailored health insights, enabling better-informed conversations with healthcare providers. We serve as a tool for preventive care and health education, helping our users recognise potential issues early and encouraging proactive healthcare management. With 1 in 4 US women using Flo, our platform is uniquely positioned to bring women's health into the 21st century, all while maintaining the highest standards of medical credibility, data privacy, and user trust."

As part of the transaction, Tanzeen Syed, Managing Director and Head of Consumer Internet and Technology at General Atlantic, and Jessie Cai, will join Flo's Board of Directors.